Condition: Macular Edema · Sponsor: Kiora Pharmaceuticals, Inc.
This is a multi-center, open label study to assess the safety, tolerability, and efficacy of KIO-104 administered by IVT injection to the study eye of eligible participants with macular edema.
This description comes directly from the study's public registry record.
Claudia Gregorio-King · +61 421 992 076 · clinical@kiorapharma.com
Always discuss trial participation with your own doctor first.
| Sydney Eye Hospital | Sydney, New South Wales, Australia | Recruiting |
| Sydney West Retina | Westmead, New South Wales, Australia | Not Yet Recruiting |
| Royal Adelaide Hospital | Adelaide, South Australia, Australia | Not Yet Recruiting |
| Hobart Eye Surgeons | Hobart, Tasmania, Australia | Recruiting |
| Centre for Eye Research Australia | East Melbourne, Victoria, Australia | Recruiting |
| Lions Eye Institute Limited | Nedlands, Western Australia, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06825702